Affymetrix of Santa Clara, Calif., said it has signed a licensing agreement with MWG-Biotech of Ebersberg, Germany, granting the German company the rights to certain Affymetrix intellectual property for commercializing low and medium density DNA arrays.
Under the terms of the license, MWG-Biotech has a non-exclusive, worldwide, royalty-bearing license that allows them to manufacture, use and sell low and medium density pre-spotted arrays.